NWU welcomes plans for academic hospital in North West
Minister Motsoaledi made this announcement during his budget vote presentation to the National Council of Provinces on Tuesday. There are currently no academic hospitals in the North West, Mpumalanga or the Northern Cape, although proposed projects in these regions are in the preliminary stages of development.
The NWU is in the advanced stages of constructing the NWU Desmond Tutu School of Medicine, and Prof. Tyobeka says that aligning this project with the proposed academic hospital in the North West would greatly benefit the citizens of the province.
The first intake of NWU Desmond Tutu School of Medicine students is scheduled for 2028.
'South Africa faces many healthcare challenges, and it is heartening to see that the public healthcare system, on which almost 90% of South Africans rely, is a high government priority. But more than a priority, healthcare is a promise to our citizens that we must keep. Therefore, I am elated by the Minister's pronouncement regarding plans in the pipeline to establish additional academic hospitals, one of which is earmarked for the North West Province,' said Prof Tyobeka.
'This development strongly supports our NWU Desmond Tutu School of Medicine, which is presently under construction. Whilst not wishing to pre-empt any formal decisions, we are hopeful that government will strategically locate this hospital in Mahikeng or within the Ngaka Modiri Molema District, in close proximity to our NWU Mahikeng Campus. Such a move would significantly enhance the university's capacity to broaden the footprint of our NWU Desmond Tutu School of Medicine beyond the Kenneth Kaunda and JB Marks Districts, thereby improving equitable access to high-calibre healthcare professionals and clinical expertise across the province.'
The integration of the NWU Desmond Tutu School of Medicine with a future academic hospital in the North West holds immense promise not only for advancing medical education, but also for transforming healthcare access and outcomes in the province.
At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TimesLIVE
7 minutes ago
- TimesLIVE
Here's how you can tally up the sugar in your favourite food and drinks
Whether you are pursuing better dietary choices for weight loss or struggling with serious conditions like diabetes, sugar intake can become a dominant concern regarding what you have in your fridge and pantry. A recent study by Wits University found that South Africans consume more than the required amount of sugar, which is estimated at 12 to 24 teaspoons daily, though the World Health Organization suggests a daily limit of six teaspoons. Laager Rooibos partner dietitian Mbali Mapholi says hidden sugars are often 'sneaky' and can add up quickly throughout the day. She adds that certain snacks and drinks 'aren't noticeably sweet' but still contain worrying amounts of sugar, which can significantly impact one's health over time. According to Mapholi, natural sugars come in the form of lactose, fructose and sucrose, which originate in fruit, vegetables, dairy and grain foods. In contrast, hidden sugars are added to foods or drinks during processing. These sugars come in many different forms from cane sugar, agave nectar, honey, maple syrup, high fructose corn syrup, molasses, honey and fruit juice concentrates.
The Citizen
5 hours ago
- The Citizen
Zishan finds life-saving stem cell donor
When nine-year-old Zishan Reddy was diagnosed with leukaemia for the second time and needed a bone marrow transplant, his mother Goolshun, family friends, and the Ashton International College community sprang into action in the hopes of finding a donor. Goolshun issued a heartfelt plea for potential donors to register with the South African Bone Marrow Registry (SABMR), while Ashton hosted a stem cell donor drive on May 30. In a show of solidarity, teacher Robyn Daniel also dedicated her June 8 Comrades Marathon run to Zishan's fight. While Goolshun says she is 'eternally grateful for the support from South Africans', she never imagined that her son's match would come from nearly 7 300km away, in India. 'When Dr Kate Bennett shared the news with Zishan, he just threw his hands up in the air and said, 'Yes, yes, yes!' I could just see the excitement in his face,' said Goolshun. 'But with all the excitement also comes some anxiety. We are just taking it day by day,' she added. ALSO READ: Robyn achieves Comrades PB for little leukemia sufferer 'All we know is that the donor is from India, and we are eternally grateful to them for giving so selflessly and being willing to save another life. We are relieved it's a great match for my little warrior, Zishan. 'We continue to pray the transplant will be an easy and painless journey for him. We trust his strength, courage and fighting spirit will carry him through.' She extended heartfelt thanks to everyone who supported them during this journey: 'We are eternally grateful for all the love and support and hope you will continue to help others still waiting for a transplant. Thank you, and God bless, from my family to yours.' She had special words for her daughter: 'To my daughter Thuraya, thank you for being the best big sister. You are such a strong, beautiful girl, and I am super proud of you. We love you very much.' She also praised Robyn Daniel for her dedication and continued support: 'A very special thank you to Robyn for her love and support of our family. It is so heart-warming and means so much to us. She has continued to keep in touch with Zishan's treatment through regular messages. She has a heart full of love and care.' Zishan recently spent five days at Netcare Unitas Hospital receiving radiation and has since been transferred to the Wits University Donald Gordon Medical Centre, where the next phase of his transplant will begin. ALSO READ: It would mean the world to Zishan if he gets a stem cell donor
Daily Maverick
15 hours ago
- Daily Maverick
More than 70 million people in Africa are living with chronic viral hepatitis
Two to three million South Africans have chronic viral hepatitis, with most remaining undiagnosed and untreated. Hepatitis occurs when different viruses cause inflammation of the liver. Hepatitis A (HAV) and hepatitis E (HEV) viruses are mainly spread through contaminated food or water and typically cause self-limiting infections. This means that following a short period of illness — ranging from mild to severe and occasionally life-threatening — the affected person usually recovers fully. In contrast, three other types of hepatitis viruses — hepatitis B (HBV), C (HCV) and D (HDV) — are transmitted mainly through contact with infected bodily fluids such as blood, saliva and semen. This may lead to chronic infection of the liver, meaning the infection persists for at least six months. Chronic infection may last for life, and carriers, as people with chronic infection are called, remain infectious and can pass the infection to their close contacts without ever knowing they are infected. The younger someone is when becoming infected, the higher the risk of developing a chronic infection. Mother-to-child transmission A mother can also pass HBV to her child during childbirth, especially when she has a high concentration of the virus in her blood. More than 90% of babies infected by their mothers will become carriers. Mother-to-child transmission of HBV is a major contributor to the global burden of chronic HBV infection. Fortunately, HBV infection can be prevented with a safe and effective vaccine. While there is no vaccine for HCV, it can be treated and cured using effective antiviral medications. Chronic HBV and HCV infections, unless recognised and treated on time, may eventually lead to serious, often fatal conditions such as liver cirrhosis or primary liver cancer. Of the more than 300 million people worldwide estimated to be living with chronic HBV or HCV infection, more than 70 million are in Africa. Two to three million South Africans have chronic viral hepatitis, with most remaining undiagnosed and untreated. Studies from our group and others have shown that chronic HBV infection is responsible for more than 60% of primary liver cancer cases in South Africa. Primary liver cancer is more common in males and tends to develop relatively early in adulthood, cutting lives short. Alarmingly, chronic infection often goes unnoticed until it causes serious complications, by which time treatment options are very limited and usually too late. Public awareness It is therefore fitting that 28 July is commemorated annually as World Hepatitis Day to raise public awareness of viral hepatitis. The theme for 2025, Hepatitis: Let's Break It Down, is aimed at dismantling various obstacles — including financial, social and systemic barriers — that stand in the way of eliminating viral hepatitis as a public health threat by 2030. South Africa has been making commendable progress towards eliminating viral hepatitis as a public health threat. The country introduced the vaccine against HBV in the Expanded Programme on Immunisation in 1995. This has led to a significant decline in the number of infections among children under the age of five. Nevertheless, some children continue to be infected because their mothers are not tested for HBV. This can be done using a simple rapid test, and if pregnant women are found to be infected with HBV, antiviral therapy will reduce the risk of transmitting the virus to their children. Pregnant women Diagnosing pregnant women with chronic hepatitis is an entry point to medical care — not only for their own health, but also that of their sexual partners and other family members who should also be screened for HBV. In 2024, South Africa started screening pregnant women for HBV and rolling out a birth dose HBV vaccine for babies born to infected mothers. This is a long-overdue move. It is still too early to evaluate its success, which depends on full commitment from all relevant stakeholders in all provinces. A simpler alternative that is less prone to implementation issues would be to administer the birth dose HBV vaccine to every baby instead of waiting until they are six weeks old, regardless of the mother's status. While eliminating new HBV infections among children is crucial, it is equally important to diagnose those who are already infected. Diagnosis is the gateway to care. This includes antiviral treatment and regular monitoring to enable early detection of liver cancer should it develop. The latest World Health Organization guidelines for management of chronic HBV infection have been simplified by abandoning previously complicated algorithms that excluded many people who could benefit from antiviral therapy. It is estimated that currently, fewer than 10% of those who should be getting treatment for chronic viral hepatitis are receiving it. Economic benefit Diagnosing and treating more chronically infected individuals requires financial resources. It is highly likely to be cost-effective from an economic standpoint, as severe illness and death affect adults in their productive years. In addition, it will kill two birds with one stone: to prevent serious illness in the infected person and to prevent new infections. The same applies to HIV: someone who is on treatment and has a low or undetectable viral load is essentially no longer infectious to others. However, there is an urgent need to identify funding mechanisms, particularly considering the current US administration's withdrawal of donor aid. It will be wise for African countries to come together and speak with one voice when entering into any negotiations with pharmaceutical companies that manufacture antivirals for chronic viral hepatitis. Societal barriers and misinformation While providing the necessary preventative and treatment methods, we also must break down societal barriers that hinder access to clinical care. We must also address misinformation. We have heard sad stories from individuals with chronic viral hepatitis during our community engagement initiatives of being ostracised within the community because of miseducation on how the infection is transmitted and its complications. Some patients with viral hepatitis have been accused of promiscuity, while in certain cases, the development of liver cancer has been blamed on witchcraft. Health educators will need to do more to educate the general public. It will also be beneficial to have functional support groups of people living with viral hepatitis, while the involvement of prominent individuals can also help to raise awareness about viral hepatitis. We can learn from public health responses to other viral infections and borrow some of the strategies to address viral hepatitis. Together we can 'break it down.' DM
